Glucagon MCQs With Answer

Glucagon MCQs With Answer provide B. Pharm students a focused review of glucagon’s physiology, pharmacology, mechanism of action, therapeutic uses and clinical implications. This set covers synthesis and processing of proglucagon, alpha‑cell secretion, glucagon receptor signaling (Gs‑protein, cAMP, PKA), hepatic glycogenolysis and gluconeogenesis, metabolic effects on adipose and heart, clinical formulations and emergency use for severe hypoglycaemia, diagnostic applications, side effects and new drug targets such as receptor antagonists. Each question reinforces molecular pathways, clinical dosing, contraindications and interpretation of lab assays to deepen understanding for exams and practical practice. Now let’s test your knowledge with 30 MCQs on this topic.

Q1. Where is glucagon primarily synthesized?

  • Pancreatic beta cells
  • Pancreatic alpha cells
  • Pancreatic delta cells
  • Intestinal L‑cells

Correct Answer: Pancreatic alpha cells

Q2. Which prohormone convertase predominantly processes proglucagon to glucagon in pancreatic alpha cells?

  • Prohormone convertase 1/3 (PC1/3)
  • Prohormone convertase 2 (PC2)
  • Dipeptidyl peptidase‑4 (DPP‑4)
  • Furin

Correct Answer: Prohormone convertase 2 (PC2)

Q3. Which G protein is coupled to the glucagon receptor?

  • Gi
  • Gs
  • Gq
  • G12/13

Correct Answer: Gs

Q4. What is the immediate hepatic metabolic action of glucagon after receptor activation?

  • Stimulates glycogenolysis
  • Stimulates glycogen synthesis
  • Increases glycolysis
  • Decreases gluconeogenesis

Correct Answer: Stimulates glycogenolysis

Q5. What is the principal second messenger mediating glucagon’s intracellular effects?

  • Inositol trisphosphate (IP3)
  • cAMP
  • Diacylglycerol (DAG)
  • Calcium ion (Ca2+)

Correct Answer: cAMP

Q6. Which enzyme is directly activated by PKA in the pathway leading to glycogen breakdown?

  • Glycogen synthase
  • Phosphorylase kinase
  • Hexokinase
  • Pyruvate dehydrogenase

Correct Answer: Phosphorylase kinase

Q7. Which clinical situation is an established indication for emergency administration of glucagon?

  • Mild hyperglycaemia
  • Severe hypoglycaemia with unconscious patient and no IV access
  • Chronic type 2 diabetes management
  • Routine postprandial glucose lowering

Correct Answer: Severe hypoglycaemia with unconscious patient and no IV access

Q8. Which routes are commonly used to administer emergency glucagon preparations?

  • Oral tablet
  • Transdermal patch
  • Intramuscular, subcutaneous or intravenous injection
  • Inhalation powder

Correct Answer: Intramuscular, subcutaneous or intravenous injection

Q9. What is the primary metabolic effect of glucagon on adipose tissue?

  • Stimulates lipogenesis
  • Stimulates lipolysis
  • Inhibits hormone‑sensitive lipase
  • No effect on lipid metabolism

Correct Answer: Stimulates lipolysis

Q10. What is the approximate plasma half‑life of endogenous glucagon?

  • 30 seconds
  • 3–6 minutes
  • 1 hour
  • 24 hours

Correct Answer: 3–6 minutes

Q11. Which hormone is considered the primary counter‑regulatory hormone to insulin during fasting?

  • Insulin
  • Glucagon
  • Somatostatin
  • GLP‑1

Correct Answer: Glucagon

Q12. Which nutrient strongly stimulates glucagon secretion from alpha cells?

  • High plasma glucose
  • Amino acids (e.g., arginine)
  • Free fatty acids
  • Ketone bodies

Correct Answer: Amino acids (e.g., arginine)

Q13. What cardiac effect can glucagon exert via increased cAMP in cardiomyocytes?

  • Negative inotropy and bradycardia
  • Positive inotropy and chronotropy
  • No direct cardiac effect
  • Only vasodilation without inotropic change

Correct Answer: Positive inotropy and chronotropy

Q14. Which therapeutic strategy targets glucagon signaling to lower hepatic glucose output in type 2 diabetes?

  • GLP‑1 receptor agonists
  • Glucagon receptor antagonists
  • SGLT2 inhibitors
  • Insulin secretagogues

Correct Answer: Glucagon receptor antagonists

Q15. In which condition is administration of glucagon relatively contraindicated due to risk of catecholamine release?

  • Pregnancy
  • Pheochromocytoma
  • Chronic kidney disease
  • Hypothyroidism

Correct Answer: Pheochromocytoma

Q16. Glucagon stimulation test is commonly used clinically to assess reserve of which pituitary axis?

  • Thyroid axis (TSH)
  • Growth hormone (GH) secretion
  • Posterior pituitary (ADH)
  • Gonadotropin axis (LH/FSH)

Correct Answer: Growth hormone (GH) secretion

Q17. Which peptide derived from proglucagon processing in intestinal L‑cells enhances insulin secretion?

  • Glucagon
  • GLP‑1 (glucagon‑like peptide‑1)
  • Somatostatin
  • Insulin‑like growth factor

Correct Answer: GLP‑1 (glucagon‑like peptide‑1)

Q18. Which organs are primarily responsible for glucagon clearance from plasma?

  • Spleen and bone marrow
  • Liver and kidney
  • Lung and thyroid
  • Pancreas and adrenal gland

Correct Answer: Liver and kidney

Q19. Which amino acid is a major gluconeogenic substrate whose uptake is promoted during glucagon action?

  • Methionine
  • Alanine
  • Lysine
  • Phenylalanine

Correct Answer: Alanine

Q20. Which intracellular enzyme is directly activated by rising cAMP following glucagon receptor activation?

  • Adenylate cyclase
  • Protein kinase A (PKA)
  • Protein kinase C (PKC)
  • Phospholipase C

Correct Answer: Protein kinase A (PKA)

Q21. Elevated glucagon-to‑insulin ratio promotes which of the following hepatic processes?

  • Decreased ketogenesis
  • Increased ketogenesis
  • Enhanced glycogen synthesis
  • Suppressed gluconeogenesis

Correct Answer: Increased ketogenesis

Q22. Which of the following is NOT a therapeutic use of glucagon?

  • Treatment of severe hypoglycaemia
  • As a radiologic agent to relax the gut in imaging
  • Diagnostic stimulation test for GH
  • Long‑term treatment to reduce chronic hyperglycaemia in diabetes

Correct Answer: Long‑term treatment to reduce chronic hyperglycaemia in diabetes

Q23. Which adverse effects are most commonly reported after therapeutic glucagon administration?

  • Severe hypertension and ischemia
  • Nausea and vomiting
  • Delayed prolonged hypoglycaemia
  • Neutropenia

Correct Answer: Nausea and vomiting

Q24. Which toxicological application of glucagon is clinically useful?

  • Treatment of beta‑blocker overdose
  • Worsening beta‑blocker toxicity
  • Contraindicated in calcium channel blocker overdose
  • Enhances effects of beta‑blockers

Correct Answer: Treatment of beta‑blocker overdose

Q25. Glucagon receptor expression is highest in which tissue?

  • Skeletal muscle
  • Liver
  • Brain cortex
  • Pancreatic beta cells

Correct Answer: Liver

Q26. How does abnormal glucagon secretion contribute to type 2 diabetes?

  • Reduced glucagon causes fasting hyperglycaemia
  • Increased glucagon contributes to elevated hepatic glucose output
  • No role in diabetic hyperglycaemia
  • Only insulin abnormalities matter in type 2 diabetes

Correct Answer: Increased glucagon contributes to elevated hepatic glucose output

Q27. Which laboratory method is commonly used to quantify circulating glucagon levels?

  • Polymerase chain reaction (PCR)
  • Enzyme‑linked immunosorbent assay (ELISA)
  • Magnetic resonance imaging (MRI)
  • Mass spectrometric lipid profiling

Correct Answer: Enzyme‑linked immunosorbent assay (ELISA)

Q28. What is the approximate amino acid length of human glucagon?

  • 10 amino acids
  • 29 amino acids
  • 100 amino acids
  • Precise steroid structure

Correct Answer: 29 amino acids

Q29. What is the effect of glucagon on hepatic pyruvate kinase activity?

  • Activates pyruvate kinase
  • Decreases pyruvate kinase activity via phosphorylation
  • No effect on pyruvate kinase
  • Converts pyruvate kinase to a constitutively active isoform

Correct Answer: Decreases pyruvate kinase activity via phosphorylation

Q30. Which gluconeogenic enzyme’s expression is induced by glucagon signalling in the liver?

  • Hexokinase
  • PEP carboxykinase (PEPCK)
  • Pyruvate kinase
  • Glycogen synthase

Correct Answer: PEP carboxykinase (PEPCK)

Leave a Comment